B
Blueprint Medicines
Biotech & Life Sciences · Cambridge, United States · Founded 2011 · IPO 2015
Blueprint Medicines mafia
Startups founded by Blueprint Medicines alumni
Former Blueprint Medicines employees who went on to start their own companies. Sorted by Dealroom signal score.
Dave JohnsonUnited States
Klaus HoeflichUnited States
Chris VarmaUnited States
Christoph LengauerUnited States
George DemetriUnited States
Alexis BorisyUnited StatesGlobal footprint
Where Blueprint Medicines has talent and traffic
team presence
across markets
Talent graph
The shape of Blueprint Medicines's talent
Dealroom maps Blueprint Medicines's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Patent intelligence
$90M patent portfolio · 80 active families
Where Blueprint Medicines concentrates vs peers
Each axis is a top-10 topic across Blueprint Medicines and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Blueprint Medicines
An AI-synthesized read of the highest-engagement posts about Blueprint Medicines on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Blueprint Medicines on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.